Adaptive Biotechnologies Corp at Cowen Healthcare Conference (Virtual) Transcript
Everybody, my name is Doug Schenkel. I'm one of the analysts with Cowen focused on the life science and diagnostic tools team. It's my pleasure to welcome you as well as Adaptive Bio to the 41st Annual Cowen and Company Health Care Conference. From the company, it's our pleasure to welcome Chad Robins, the company's Co-Founder and Chief Executive Officer. Thanks for being here, Chad. We always appreciate the time.
Thanks, Doug, for having me. I appreciate it.
So for those of you new to the story, Adaptive's immune profiling platform is well-validated and its product pipeline continues to advance with over 380 issued and 60 pending patents. I think that's what we were up to a last count, I'm sure it continues to grow. Chad and his team have
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |